Coca-Cola (NYSE: KO) earnings on April 28: What the new CEO era means for dividend investors

The Coca-Cola Company (NYSE: KO) is heading into its first quarterly earnings report under new chief executive Henrique Braun, with results due before the NYSE opens on April 28. Trading at around USD 78 near the top of its 52-week range, the stock is carrying the weight of a new leadership era, an unresolved tariff environment, a growing debate about GLP-1 drugs and beverage volumes, and a dividend streak that has now run for 64 consecutive years. For retail investors sitting on the fence, the next two weeks crystallise a lot of what makes KO either a conviction hold or an overvalued comfort blanket.

Braun, who joined Coca-Cola in 1996 and served as chief operating officer before stepping up on March 31, has wasted little time in signalling his direction. His first public comments as CEO centred on understanding consumers more deeply and accelerating technology adoption across the enterprise. James Quincey, his predecessor and architect of the “total beverage company” strategy that added more than ten billion-dollar brands to the portfolio, remains as executive chairman. The handover is engineered for continuity, but the market will be watching the April 28 call to hear Braun’s own voice on guidance, capital allocation, and how he plans to address the structural headwinds that have been building since at least 2023.

What is Coca-Cola’s total beverage company model and why does it matter to investors right now?

Coca-Cola is not simply a carbonated soft drinks business. That framing, which still dominates casual investor conversation, misses the scale of what the company has assembled over the past decade. The portfolio now spans Sprite, Fanta, and Coca-Cola Zero Sugar in sparkling drinks, as well as BODYARMOR, Powerade, smartwater, Dasani, vitaminwater, Topo Chico, Costa Coffee, Gold Peak Tea, and Fairlife in adjacent categories. It operates across more than 200 countries and territories and sells through an asset-light bottling system where independent bottlers handle most of the capital-intensive manufacturing and distribution. Coca-Cola concentrates and syrups to bottlers, collects a margin on that concentrate, and takes a relatively insulated position from raw material cost swings compared to a vertically integrated manufacturer.

This model is central to the investment case because it generates unusually high gross margins. The company reported a gross margin of approximately 62% and an operating margin of around 29% in its most recent annual results. Free cash flow for 2025 came in at approximately USD 5.3 billion on a reported basis, and the company has guided for roughly USD 12.2 billion in free cash flow for 2026 once a one-off Fairlife acquisition payment clears the prior-year comparison. Net debt leverage stood at 1.6 times EBITDA at the end of 2025, which is conservative for a business of this quality and scale.

The reason this matters right now is that the total beverage model is being tested simultaneously by tariff costs on aluminium packaging, the GLP-1 weight-loss drug phenomenon, shifting consumer preferences in developed markets, and currency headwinds from a strong US dollar. How durable the model’s margins prove under this combination is the central question heading into the April 28 print.

How has the leadership transition from James Quincey to Henrique Braun changed the risk profile for KO shareholders?

CEO transitions at companies with deeply embedded operating models and entrenched franchise systems rarely cause structural disruption. Coca-Cola’s bottling network, brand portfolio, and pricing power do not change because a different executive is sitting in the chair. Braun has been inside the organisation since 1996 and held the COO role, which means he ran operations before being handed the keys. Quincey’s decision to remain as executive chairman provides an additional continuity layer that most succession announcements lack.

That said, any new CEO is tested by the first set of results they own, and Braun will face questions on April 28 that go beyond operational boilerplate. Investors will want clarity on his read of the US consumer, his stance on M&A following the Fairlife acquisition, and whether he intends to revisit the Costa Coffee strategy in Europe and Asia, which has been a topic of quiet speculation around a potential sale. Quincey had telegraphed that the company was in early-stage discussions around Costa earlier in 2025, and analysts will probe whether that process is alive under the new CEO.

The leadership transition also comes at a point where the stock is trading close to its all-time high. At around USD 78, KO is valued at roughly 25 times normalised earnings. That is not cheap for a business growing organic revenue in the mid-single digits. The multiple is essentially a bet on Braun’s ability to maintain Quincey-era execution while navigating the new macro environment. If the April 28 call delivers a confident full-year guidance reaffirmation, the premium will likely hold. A guidance cut or a cautious tone on volumes would test it quickly.

Why are aluminium tariffs a complicated but manageable problem for Coca-Cola rather than an existential threat?

The Trump administration’s tariffs on aluminium imports, which reached 50% at the height of the trade war, raised legitimate concerns about packaging costs for the US beverage industry. Coca-Cola’s asset-light model means the company does not directly bear those costs in its own manufacturing, but it is not fully insulated either. Its independent bottlers buy aluminium cans, and if their costs rise sharply, the pressure eventually flows back through the system in the form of lower marketing investment, reduced promotional activity, or pressure on Coca-Cola’s concentrate prices.

Former CFO John Murphy characterised aluminium as a relatively small part of the overall input mix and described the impact as manageable within a multi-billion dollar supply chain. Quincey flagged that Coca-Cola could shift volumes toward PET plastic bottles if aluminium costs remained elevated, a lever the company has used in other markets. The company also has extensive supplier relationships and hedging programmes that smooth short-term commodity moves. The Supreme Court’s ruling in early 2026 that country-specific reciprocal tariffs under IEEPA were unconstitutional removed some of the broader tariff risk for the consumer sector, though Section 232 aluminium tariffs, which are authorised under a separate legal basis, remain in place.

The practical investor question is whether Coca-Cola can absorb or pass through the aluminium cost without visible damage to volume. In North America, the company raised prices by 8% in the most recent comparable period and unit case volumes fell 3%. That volume-price trade-off is being watched carefully. If Braun signals on April 28 that pricing is close to its ceiling and volumes are not recovering, that would be a more concerning data point than the tariff cost itself.

What does Coca-Cola Zero Sugar’s growth trajectory reveal about how the business is navigating the GLP-1 era?

GLP-1 weight-loss drugs like semaglutide and tirzepatide have generated significant debate in consumer staples investment circles. The concern is straightforward: if tens of millions of people are taking appetite-suppressing medications, they will drink less soda. The data so far is more nuanced. Coca-Cola Zero Sugar grew by 14% globally across all regions in the first quarter of 2025. That number suggests the low-and-no-sugar segment is benefiting, at least in part, from health-conscious behaviour that is not exclusively driven by GLP-1 use.

Quincey’s own public commentary on GLP-1s was measured. He acknowledged that users tend to drink less full-sugar soft drinks but noted a corresponding increase in consumption of diet variants, hydration products, coffee, and protein beverages. That pattern plays reasonably well for Coca-Cola’s portfolio breadth. BODYARMOR and smartwater are positioned for the health and hydration shift, and Fairlife’s protein products are directly aligned with the post-GLP-1 dietary profile that emphasises high protein intake to preserve muscle mass during rapid weight loss.

The broader risk is structural rather than immediate. GLP-1 penetration remains low globally, with roughly 2% of the obese population currently using these medications. Oral formulations approved by the FDA in late 2025 are expected to expand access significantly over the next two to three years. If oral GLP-1 adoption accelerates as projected, the full-sugar CSD category in developed markets faces a long-term secular headwind that no amount of product reformulation fully offsets. Coca-Cola’s portfolio diversification is the best hedge available, but investors should treat this as a slow-moving structural risk to watch rather than a near-term earnings driver.

How is Coca-Cola’s global market pricing the stock against what the Q1 2026 earnings release is likely to show?

Consensus analyst estimates put Q1 2026 earnings per share at approximately USD 0.82, up from the USD 0.73 reported in Q1 2025. Management has guided for full-year organic revenue growth of 4% to 5% and comparable EPS growth of 7% to 8% against a 2025 base of USD 3 per share, implying a 2026 comparable EPS range of roughly USD 3.21 to USD 3.24. A USD 1 currency tailwind to EPS was factored into guidance, which partially offsets the divestiture headwind from the expected sale of Coca-Cola Beverages Africa in the second half of 2026.

At USD 78, the stock trades at about 24 times the forward EPS guidance midpoint. That is a slight premium to the historical average forward multiple for KO, which has typically ranged between 20 and 25 times earnings depending on the market cycle. Analysts across the buy-side have been broadly constructive. UBS lifted its price target to USD 90, RBC Capital Markets and Wells Fargo maintained buy ratings, and Deutsche Bank raised its target to USD 86. Goldman Sachs is the outlier with a hold rating. The consensus 12-month price target sits near USD 84, implying approximately 7% upside from current levels before the dividend yield is added.

The stock’s beta of 0.20 tells a separate story. KO barely moves with the broader market, which is partly why it attracts investors during volatile macro periods. Since February’s Supreme Court tariff ruling and the broader market turbulence following Trump’s reciprocal tariff announcements, consumer staples as a sector have seen inflows from investors rotating out of growth-sensitive names. KO has been a direct beneficiary of that rotation and is now near its 52-week high of USD 82.

What does Warren Buffett’s Coca-Cola position teach retail investors about the compounding logic behind KO shares?

Berkshire Hathaway owns 400 million shares of Coca-Cola, representing a stake of approximately 9.3% in the company. Buffett accumulated that position between 1988 and 1994 at a total cost of roughly USD 1.3 billion. The current annual dividend income flowing to Berkshire from that holding is approximately USD 816 million, which breaks down to around USD 204 million per quarter. The dividend Berkshire collects each year now exceeds half of the original purchase price, and the position has never been sold.

Coca-Cola raised its dividend for the 64th consecutive year in early 2026, maintaining its status as one of a small group of Dividend Kings. The current annual dividend rate is USD 2.06 per share, producing a yield of approximately 2.7% at the current share price. For a retail investor buying today, the starting yield is modest, but the compounding logic that makes the Buffett story so discussed online applies to any patient holder. A company that has raised its dividend for 64 consecutive years through wars, recessions, pandemics, and trade wars has an exceptional track record of translating earnings growth into shareholder income.

The retail investor community discusses this stock heavily on platforms including Reddit’s investing and dividends communities, X cashtag activity around KO, and dividend-focused forums. The dominant theme is not short-term trading but income accumulation. For income-focused retail investors, the April 28 print is less about the headline EPS beat and more about whether management reaffirms the full-year earnings trajectory that supports continued dividend growth through 2026 and beyond.

What execution risks could disrupt the Coca-Cola investment thesis between now and the end of 2026?

Volume pressure in North America is the most visible near-term risk. An 8% price increase in the most recent comparable period delivered a 3% unit case volume decline. If that volume weakness persists or spreads to other geographies, it suggests Coca-Cola is approaching the limit of its pricing power in developed markets, which is the primary lever the company has used to protect margins since 2021. The April 28 results will provide the first real read on whether volume trends are stabilising in Q1.

Currency remains a structural headwind for a business that generates the majority of its revenue outside the United States. Management has guided for a 3% EPS tailwind from currency in 2026, but that assumption is based on a specific dollar trajectory. A material move in the US dollar against key emerging market currencies could reverse that tailwind quickly, as it did during parts of 2024 and early 2025. India, China, and Brazil are Coca-Cola’s largest growth markets by volume and any macro deterioration in those economies would have an outsized effect on the top line.

The Coca-Cola Beverages Africa divestiture, expected to complete in the second half of 2026, creates a temporary earnings headwind of roughly 4 percentage points on comparable net revenue. Execution risk on that transaction, whether from regulatory delays or buyer financing conditions, could shift the timing and affect how management frames the second-half outlook. Finally, the Costa Coffee strategy remains unresolved. If a sale or structural change to the Costa business is announced under Braun, it could either unlock value or signal uncertainty about the company’s international direct retail ambitions.

Key takeaways for retail investors watching Coca-Cola (KO) ahead of April 28 earnings

• The Q1 2026 earnings report on April 28 is the first major test for new CEO Henrique Braun, who took over from James Quincey on March 31. Consensus expects EPS of USD 0.82, and the market will be watching whether management reaffirms full-year guidance for 7% to 8% comparable EPS growth.
• Coca-Cola’s 64-year consecutive dividend growth streak and USD 2.06 annual dividend per share make it a core holding for income investors. The current yield of approximately 2.7% is modest at today’s price, but the compounding track record over decades is what the Buffett argument is really about.
• Aluminium tariffs under Section 232 remain in place and create indirect cost pressure through the bottling system, but the company has multiple levers, including PET bottle substitution and concentrate pricing, to manage the impact without a guidance revision.
• Coca-Cola Zero Sugar grew 14% globally in the most recent comparable period, indicating that the portfolio is adapting to health-conscious consumer behaviour and the early stages of the GLP-1 shift rather than being disrupted by it.
• The stock is trading near its 52-week high at a forward PE of approximately 24 times, which is near the top of its historical range. Buy-side consensus is constructive with an average price target around USD 84, but Goldman Sachs is at hold, flagging valuation.
• The longer-term structural risk is secular decline in full-sugar carbonated soft drink consumption in developed markets, a trend that GLP-1 drug adoption is likely to accelerate. Portfolio diversification into BODYARMOR, Fairlife, Costa, and smartwater is the company’s primary hedge.
• Volume trends in North America and currency assumptions are the two variables most likely to determine whether the stock holds its premium multiple through the second half of 2026.